Journal of International Oncology ›› 2020, Vol. 47 ›› Issue (1): 51-55.doi: 10.3760/cma.j.issn.1673-422X.2020.01.010
• Reviews • Previous Articles Next Articles
Zhou Huiping1,2, Li Yuhua2, Wang Yuhui1, Su Yilong1, Yang Yingying1, Xu Xiaotian1, Duan Xiaoqun1()
Received:
2019-11-23
Revised:
2019-12-01
Online:
2020-01-08
Published:
2020-03-22
Contact:
Duan Xiaoqun
E-mail:duanxiaoqun66@sohu.com
Zhou Huiping, Li Yuhua, Wang Yuhui, Su Yilong, Yang Yingying, Xu Xiaotian, Duan Xiaoqun. Preventive and therapeutic effects of common plant drugs on colon cancer and its mechanism[J]. Journal of International Oncology, 2020, 47(1): 51-55.
[1] | Bray F, Ferlay J, Soerjomataram I , et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018,68(6):394-424. DOI: 10.3322/caac.21492. |
[2] | Chen W, Zheng R, Baade PD , et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016,66(2):115-132. DOI: 10.3322/caac.21338. |
[3] | Maresso KC, Tsai KY, Brown PH , et al. Molecular cancer prevention: current status and future directions[J]. CA Cancer J Clin, 2015,65(5):345-383. DOI: 10.3322/caac.21287. |
[4] | Kumar G, Mittal S, Sak K , et al. Molecular mechanisms underlying chemopreventive potential of curcumin: current challenges and future perspectives[J]. Life Sci, 2016,148:313-328. DOI: 10.1016/j.lfs.2016.02.022. |
[5] | 杨芳, 刘少琼, 李春花 , 等. 姜黄素下调结直肠癌细胞Notch1信号通路研究[J]. 湖南中医药大学学报, 2015, 35(4): 10-13, 50, 封3. DOI: 10.3969/j.issn.1674-070X.2015.04.003. |
[6] | Sankpal UT, Nagaraju GP, Gottipolu SR , et al. Combination of tolfenamic acid and curcumin induces colon cancer cell growth inhibition through modulating specific transcription factors and reactive oxygen species[J]. Oncotarget, 2016,7(3):3186-3200. DOI: 10.18632/oncotarget.6553. |
[7] | Radhakrishnan VM, Kojs P, Young G , et al. pTyr421 cortactin is overexpressed in colon cancer and is dephosphorylated by curcumin: involvement of non-receptor type 1 protein tyrosine phosphatase (PTPN1)[J]. PLoS One, 2014,9(1):e85796. DOI: 10.1371/journal.pone.0085796. |
[8] | Zhang L, Cheng X, Gao Y , et al. Curcumin inhibits metastasis in human papillary thyroid carcinoma BCPAP cells via down-regulation of the TGF-β/Smad2/3 signaling pathway[J]. Exp Cell Res, 2016,341(2):157-165. DOI: 10.1016/j.yexcr.2016.01.006. |
[9] | 陈贵娥, 唐源, 刘满英 , 等. 苹果多糖抑制人结肠癌细胞SW-620转移的作用及机制研究[J]. 现代肿瘤医学, 2019,27(12):2040-2044. |
[10] | 张典, 王粉侠, 弥曼 , 等. 苹果多糖预防小鼠结肠炎癌变的作用及其机制研究[J]. 中国药学杂志, 2015,50(17):1527-1531. DOI: 10.11669/cpj.2015.17.015. |
[11] | Liu Y, Zhao J, Zhao Y , et al. Therapeutic effects of lentinan on inflammatory bowel disease and colitis-associated cancer[J]. J Cell Mol Med, 2019,23(2):750-760. DOI: 10.1111/jcmm.13897. |
[12] | Suga Y, Takehana K . Lentinan diminishes apoptotic bodies in the ileal crypts associated with S-1 administration[J]. Int Immunopharmacol, 2017,50:55-60. DOI: 10.1016/j.intimp.2017.06.012. |
[13] | Wang J, Li W, Huang X , et al. A polysaccharide from Lentinus edodes inhibits human colon cancer cell proliferation and suppresses tumor growth in athymic nude mice[J]. Oncotarget, 2017,8(1):610-623. DOI: 10.18632/oncotarget.13481. |
[14] | Li Y, Sun Y, Fan L , et al. Paris saponin Ⅶ inhibits growth of colorectal cancer cells through Ras signaling pathway[J]. Biochem Pharmacol, 2014,88(2):150-157. DOI: 10.1016/j.bcp.2014.01.018. |
[15] | Zhou H, Sun Y, Zheng H , et al. Paris saponin Ⅶ extracted from trillium tschonoskii suppresses proliferation and induces apoptosis of human colorectal cancer cells[J]. J Ethnopharmacol, 2019,239:111903. DOI: 10.1016/j.jep.2019.111903. |
[16] | Chen M, Ye K, Zhang B , et al. Paris saponin Ⅱ inhibits colorectal carcinogenesis by regulating mitochondrial fission and NF-κB pathway[J]. Pharmacol Res, 2019,139:273-285. DOI: 10.1016/j.phrs.2018.11.029. |
[17] | 于思 . 重楼皂苷Ⅰ诱导ROS蓄积介导结肠癌细胞周期阻滞和自噬的研究[D]. 成都: 成都中医药大学, 2018. |
[18] | Han S, Jeong AJ, Yang H , et al. Ginsenoside 20(S)-Rh2 exerts anti-cancer activity through targeting IL-6-induced JAK2/STAT3 pathway in human colorectal cancer cells[J]. J Ethnopharmacol, 2016,194:83-90. DOI: 10.1016/j.jep.2016.08.039. |
[19] | Wang J, Chen Y, Dai C , et al. Ginsenoside Rh2 alleviates tumor-associated depression in a mouse model of colorectal carcinoma[J]. Am J Transl Res, 2016,8(5):2189-2195. |
[20] | Tang YC, Zhang Y, Zhou J , et al. Ginsenoside Rg3 targets cancer stem cells and tumor angiogenesis to inhibit colorectal cancer progre-ssion in vivo[J]. Int J Oncol, 2018,52(1):127-138. DOI: 10.3892/ijo.2017.4183. |
[21] | Yang X, Zou J, Cai H , et al. Ginsenoside Rg3 inhibits colorectal tumor growth via down-regulation of C/EBPβ/NF-κB signaling[J]. Biomed Pharmacother, 2017, 1240-1245. DOI: 10.1016/j.biopha.2017.11.092. |
[22] | Qiu R, Qian F, Wang X , et al. Targeted delivery of 20(S)-ginse-noside Rg3-based polypeptide nanoparticles to treat colon cancer[J]. Biomed Microdevices, 2019,21(1):18. DOI: 10.1007/s10544-019-0374-0. |
[23] | Phi LTH, Wijaya YT, Sari IN , et al. The anti-metastatic effect of ginsenoside Rb2 in colorectal cancer in an EGFR/SOX2-dependent manner[J]. Cancer Med, 2018,7(11):5621-5631. DOI: 10.1002/cam4.1800. |
[24] | Chen H, Jin ZL, Xu H . MEK/ERK signaling pathway in apoptosis of SW620 cell line and inhibition effect of resveratrol[J]. Asian Pac J Trop Med, 2016,9(1):49-53. DOI: 10.1016/j.apjtm.2015.12.010. |
[25] | Du Z, Zhou F, Jia Z , et al. The hedgehog/Gli-1 signaling pathways is involved in the inhibitory effect of resveratrol on human colorectal cancer HCT116 cells[J]. Iran J Basic Med Sci, 2016,19(11):1171-1176. |
[26] | Demoulin B, Hermant M, Castrogiovanni C , et al. Resveratrol induces DNA damage in colon cancer cells by poisoning topoisomerase Ⅱ and activates the ATM kinase to trigger p53-dependent apoptosis[J]. Toxicol In Vitro, 2015,29(5):1156-1165. DOI: 10.1016/j.tiv.2015.04.015. |
[27] | Nana AW, Wu SY, Yang YS , et al. Nano-diamino-tetrac (NDAT) enhances resveratrol-induced antiproliferation by action on the RRM2 pathway in colorectal cancers[J]. Horm Cancer, 2018,9(5):349-360. DOI: 10.1007/s12672-018-0334-9. |
[28] | Karimi Dermani F, Saidijam M, Amini R , et al. Resveratrol inhibits proliferation, invasion, and epithelial-mesenchymal transition by increasing miR-200c expression in HCT-116 colorectal cancer cells[J]. J Cell Biochem, 2017,118(6):1547-1555. DOI: 10.1002/jcb.25816. |
[29] | Darband SG, Kaviani M, Yousefi B , et al. Quercetin: a functional dietary flavonoid with potential chemo-preventive properties in colo-rectal cancer[J]. J Cell Physiol, 2018,233(9):6544-6560. DOI: 10.1002/jcp.26595. |
[30] | Roy S, Das R, Ghosh B , et al. Deciphering the biochemical and molecular mechanism underlying the in vitro and in vivo chemotherapeutic efficacy of ruthenium quercetin complex in colon cancer[J]. Mol Carcinog, 2018,57(6):700-721. DOI: 10.1002/mc.22792. |
[31] | Ahmed HH, Aglan HA, Zaazaa AM , et al. Quercetin confers tumoricidal activity through multipathway mechanisms in a N-methylnitrosourea rat model of colon cancer[J]. Asian Pac J Cancer Prev, 2016,17(11):4991-4998. DOI: 10.22034/APJCP.2016.17.11.4991. |
[32] | Yang Y, Wang T, Chen D , et al. Quercetin preferentially induces apoptosis in KRAS-mutant colorectal cancer cells via JNK signaling pathways[J]. Cell Biol Int, 2019,43(2):117-124. DOI: 10.1002/cbin.11055. |
[33] | Zhang Z, Li B, Xu P , et al. Integrated whole transcriptome profiling and bioinformatics analysis for revealing regulatory pathways associ-ated with quercetin-induced apoptosis in HCT-116 cells[J]. Front Pharmacol, 2019,10:798. DOI: 10.3389/fphar.2019.00798. |
[34] | Langner E, Lemieszek MK, Rzeski W . Lycopene, sulforaphane, quercetin, and curcumin applied together show improved antiprolife-rative potential in colon cancer cells in vitro[J]. J Food Biochem, 2019,43(4):e12802. DOI: 10.1111/jfbc.12802. |
[1] | Chu Xuelei, Mao Yun, Xue Peng, Li Linlu, Chen Meichi, Yuan Chunsheng, Qin Xiaoyan, Zhu Shijie. Effects of chemotherapy dose intensity on short-term efficacy in patients with advanced colon cancer: a study based on real-world data [J]. Journal of International Oncology, 2022, 49(7): 408-415. |
[2] | Wang Liwei, Liang Hongsheng, Du Songlin, Chen Zhihao, Wang Qing, Gao Aili. Research progress of avermectins in anti-tumor [J]. Journal of International Oncology, 2022, 49(6): 353-356. |
[3] | Laibijiang Wusiman, Cao Bowei, Zhang Wenbin, Gao Hua. Effects of exogenous AGR2 on the proliferation and invasion abilities of colon cancer cells [J]. Journal of International Oncology, 2022, 49(2): 73-78. |
[4] | Yang Chi, Luo Changjiang. Research progress on the background of inflammation, immunity and cholesterol metabolism in colorectal cancer [J]. Journal of International Oncology, 2022, 49(10): 630-634. |
[5] | Guo Shihao, Ren Yeqing, Guo Geng. Molecular mechanism of vasculogenic mimicry in brain glioma [J]. Journal of International Oncology, 2021, 48(6): 362-365. |
[6] | Li Qianqian, Zhu Xiaodi, Zhao Ronglan, Peng Xiaoxiang. Role of P2X7 receptor in colon cancer progression [J]. Journal of International Oncology, 2021, 48(4): 250-253. |
[7] | Zhao Gaochuan, Chen Qingqi, Pang Li, Cheng Zheng, Mai Fangqi. Serum levels and clinical significances of miR-205 and miR-221 in patients with colon cancer [J]. Journal of International Oncology, 2019, 46(9): 526-530. |
[8] | Liang Biyu, He Weiming, He Xiaoyi, Ding Yuanlin, Yu Haibing. Diabetes, hypoglycemic drugs and pancreatic cancer [J]. Journal of International Oncology, 2018, 45(3): 183-186. |
[9] | QIU Mei-Qing, WANG Tao, TONG Zhong-Sheng, JIA Yong-Sheng. Effects and mechanism of overexpression of Mfn2 gene on photodynamic therapy sensitivity of T47D cells in human breast cancer [J]. Journal of International Oncology, 2017, 44(8): 641-646. |
[10] | HUANG Jiang, ZHANG Sheng-Jun, BAI Li-Jie, CHANG Qi. Relationship between the decrease of serum level of carcinoembryonic antigen during perioperative period and the prognosis in patients with colon cancer [J]. Journal of International Oncology, 2017, 44(8): 662-667. |
[11] | 黄虞,杜冀晖,龚慧,王秀,王磊,李一凡. miR-92a promotes colorectal cancer cell proliferation by regulation of KLF4 gene expression [J]. Journal of International Oncology, 2017, 44(11): 812-818. |
[12] | Wan Lijuan, Chen Mingwei. Relationship between insulin resistance related factors and colon cancer stem cells [J]. Journal of International Oncology, 2017, 44(10): 790-793. |
[13] | Xiong Ting, Li Liding, Yan Xin, Xie Feiyan, Liao Caiqin, Lu Kaiqiang, Liu Xiaowang, Tu Jian. The mechanism of Genistein in the genesis and development of malignant tumor [J]. Journal of International Oncology, 2016, 43(8): 609-611. |
[14] | Wang Yanjun, Jiang Yongxin, Liu Shan, Wang Hong, Ge Lyu. Radiosensitization of artemisinin and its derivatives in tumors [J]. Journal of International Oncology, 2016, 43(8): 612-614. |
[15] | GAN Ya-Ping, GUO Xiao-Hua, ZHANG Jun-Yu, XU Qing-Qing, WU Jiang, WANG Ren-Yong, QIU Min, JIANG Ru-Gang, LIU Fu-Xing, NING Zhi-Feng. Construction of colonic cancer drugresistant cell line COLO and its relationship with tumor stem cells [J]. Journal of International Oncology, 2016, 43(8): 646-650. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||